Abstract:Endometriosis is a complex disease characterized by inflammation and the growth of endometrial- like glands and stroma outside the uterine cavity. The pathophysiology of endometriosis is not entirely understood, however, with a prevalence of ~10% of women in their reproductive years, the disease symptoms significantly affect the quality of life of millions of women globally. Metabolomic studies have previously identified specific metabolites that could be a signature of endometriosis. This approach could potentially be used as a non-invasive tool for early diagnosis and provide a better understanding of endometriosis pathophysiology. This review aims to provide insight as to how endometriosis affects the metabolome by reviewing different studies that have used this approach to design follow-up studies. The search query included the term 'endometriosis' in combination with 'metabolomics', 'lipidomics', or 'sphingolipidomics' published between 2012 and 2020. We included studies in humans and animal models. Most studies reported differences in the metabolome of subjects with endometriosis in comparison to healthy controls and used samples taken from serum, endometrial tissue, follicular fluid, urine, peritoneal fluid, or endometrial fluid. Statistically significant metabolites contributed to group separation between patients and healthy controls. Reported metabolites included amino acids, lipids, organic acids, and other organic compounds. Differences in methods, analytical techniques, and the presence of confounding factors can interfere with results and interpretation of data. Metabolomics seems to be a promising tool for identifying significant metabolites in patients with endometriosis. Nonetheless, more investigation is needed in order to understand the significance of the study results. Lay summary: Endometriosis is a chronic disease affecting the quality of life in one out of every ten women during their reproductive years, causing pain and infertility. It is characterized by inflammation and growth of tissue like the endometrium (uterus lining) outside the uterine cavity. Studies have searched for a predictor of endometriosis-associated changes by observing small molecules necessary for metabolism on a large scale (metabolomics). Metabolomics could serve to resolve one of the biggest challenges that patients with endometriosis face: a delay in diagnosis. In this review, the authors summarize identified potential biomarkers from various bodily fluids and tissues that are characteristic of metabolic processes observed in endometriosis. Biomarkers include cell growth, cell survival, high energy demand, oxidative stress, and fatty acid levels. A metabolomics approach offers promise as a non-invasive tool to identify significant metabolite changes in patients with endometriosis, potentially leading to earlier diagnoses and new opportunities for back-translational strategies.

Metabolomics for the identification of biomarkers in endometriosis

Metabolomics in endometriosis: challenges and perspectives for future studies

Challenges in uncovering non-invasive biomarkers of endometriosis

Is there a role for small molecule metabolite biomarkers in the development of a diagnostic test for endometriosis?

Serum Metabolites as Diagnostic Biomarkers in Patients with Endometriosis

Proteomics approach to discovering non-invasive diagnostic biomarkers and understanding the pathogenesis of endometriosis: a systematic review and meta-analysis

Omics-based novel strategies in the diagnosis of endometriosis

An integrated multi-tissue approach for endometriosis candidate biomarkers: a systematic review

Identification of distinct stool metabolites in women with endometriosis for non-invasive diagnosis and potential for microbiota-based therapies

Metabolic Profile of Patients with Severe Endometriosis: a Prospective Experimental Study

Hormonal Biomarkers for the Noninvasive Diagnosis of Endometriosis

Identification of Serum Markers for Endometriosis − A Proteomic Approach

Diagnostic Potential of Cytokine Biomarkers in Endometriosis: Challenges and Insights

Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis

Current biomarkers for the detection of endometriosis

Development and Validation of an Endometriosis Diagnostic Method Based on Serum Biomarkers and Clinical Variables

Endometriosis: Epidemiology, Diagnosis and Clinical Management

Circulating microRNAs as Non-Invasive Biomarkers in Endometriosis Diagnosis—A Systematic Review

Endometriosis: A Malignant Fingerprint

Bioinformatics identification and validation of biomarkers and infiltrating immune cells in endometriosis

UPLC-Q-TOF/MS Based Plasma Metabolomics for Identification of Paeonol's Metabolic Target in Endometriosis